I have to think RP is aware of that philosophy bc he probably could have held out for a more lucrative offer for Prostagene. But he knew the deal that he made with CYDY was likely to become a great long-term partnership.
Like I’ve said before, get HIV combo and the prostate test licensed for a reasonable amount, even if it’s a little less than CYDY thinks it’s worth. As long as the company gets enough cash to fund the mono and TNBC trial, we should be good.
News 
Market Data 
Discover 
AI
